Strength
40 mg/mL
Manufacturer
McKessonNDC
63739099764
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204494FDA Approved
3/12/2014
TE Code
AT
On Market Since
6/27/2024
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 4% SOLUTION has been published 307 times since Oct 28, 2020, and over the history we have for it it has declined 70.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2220 per ML |
|---|---|
| All-time high | $0.7425 (Nov 11, 2020) |
| All-time low | $0.1999 (Jul 17, 2024) |
| 52-week high | $0.3584 |
| 52-week low | $0.2046 |
| Median price | $0.4139 |
| Average price | $0.3972 |
| Largest weekly change | +74.9% (Sep 22, 2021) |
| Weeks tracked | 307 |
| Tracking since | Oct 28, 2020 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
McKesson manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 4% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 4% SOLUTION, manufactured by McKesson, is $0.2220 per ML (NDC 63739099764), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 4% SOLUTION changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 4% SOLUTION has declined 70.1%. It has been tracked across 307 weekly CMS publications since Oct 28, 2020.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 4% SOLUTION?
Since Oct 28, 2020, the NADAC for LIDOCAINE HCL 4% SOLUTION has ranged from a low of $0.1999 (Jul 17, 2024) to a high of $0.7425 (Nov 11, 2020), with a median of $0.4139 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 4% SOLUTION?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIDOCAINE HCL 4% SOLUTION in a comparable dosage form, but none are currently priced below it.
Who manufactures LIDOCAINE HCL 4% SOLUTION?
LIDOCAINE HCL 4% SOLUTION (NDC 63739099764) is labeled by McKesson, and CMS classifies it as a generic product.